Comprehensive medication guide to Insulin Analog, Lispro Mixed including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$35/month cap for Medicare Part D patients under the Inflation Reduction Act; $35/month cap for commercially insured patients via the Lilly Insulin Value Program; typical commercial copay $10–$50 depending on formulary tier.
Estimated Cash Pricing
$150–$280 retail for Humalog Mix 75/25 (10 mL vial) without discounts; as low as $81 with GoodRx or SingleCare coupons; $35/month with the Lilly Insulin Value Program for eligible patients.
Medfinder Findability Score
55/100
Summarize with AI
On this page
Insulin Analog, Lispro Mixed is a premixed injectable insulin product that combines two forms of insulin lispro in fixed proportions. Sold under the Humalog Mix brand by Eli Lilly and Company, it is available in two formulations: Humalog Mix 75/25 (75% insulin lispro protamine and 25% insulin lispro) and Humalog Mix 50/50 (50% of each). Both are available as 10 mL vials and KwikPen prefilled injection pens.
This medication is FDA-approved to improve blood sugar control in adults (18 years and older) with Type 1 or Type 2 diabetes mellitus. It is a prescription medication and is not suitable for use in insulin infusion pumps. The rapid-acting component (insulin lispro) provides mealtime blood sugar coverage within 10–20 minutes of injection, while the intermediate-acting component (insulin lispro protamine) provides background control for up to 24 hours.
Insulin Analog, Lispro Mixed is classified as an antidiabetic agent combining a rapid-acting and intermediate-acting insulin analog. It is not a controlled substance and can be prescribed by any licensed prescriber including primary care physicians, nurse practitioners, and physician assistants.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Insulin Analog, Lispro Mixed works through two simultaneous mechanisms after subcutaneous injection. The rapid-acting insulin lispro component is absorbed into the bloodstream within 10–20 minutes and binds to insulin receptors on muscle, fat, and liver cells. This binding facilitates glucose uptake from the bloodstream into cells and suppresses hepatic glucose production, lowering postmeal blood sugar within minutes.
The intermediate-acting insulin lispro protamine component exists as microscopic crystals (created by combining insulin lispro with protamine sulfate) that dissolve slowly over many hours, providing sustained background insulin activity for up to 24 hours. This phase suppresses hepatic glucose output between meals and overnight. Together, these two phases provide both mealtime and background glycemic control in a twice-daily injection regimen.
Insulin lispro is an analog of human insulin — its amino acid sequence is modified (lysine and proline are reversed at positions B28 and B29) to prevent molecular clustering after injection, enabling faster absorption than regular human insulin. This faster onset is what allows it to be injected just 15 minutes before a meal rather than 30 minutes.
100 units/mL (75% lispro protamine / 25% lispro) — injectable suspension (vial and KwikPen)
Humalog Mix 75/25 — most commonly prescribed formulation; twice-daily subcutaneous injection within 15 minutes before a meal
100 units/mL (50% lispro protamine / 50% lispro) — injectable suspension (vial and KwikPen)
Humalog Mix 50/50 — higher rapid-acting component; twice-daily subcutaneous injection within 15 minutes before a meal
Insulin Analog, Lispro Mixed has an intermediate findability profile in 2026. While it is not on the FDA national shortage list, patients frequently encounter localized stockouts at individual pharmacies. Eli Lilly discontinued the 3 mL vial format in early 2024, and the subsequent supply disruption has created uneven distribution across the country. The 10 mL vial and KwikPen formats are produced and available nationally, but not every pharmacy stocks them reliably.
The mixed formulations (75/25 and 50/50) have more limited generic competition than plain insulin lispro, which means fewer backup suppliers when demand spikes. Patients in rural areas or those dependent on a single retail pharmacy are most affected. Calling multiple pharmacies — or using a service like medfinder to check availability — is often necessary to find stock on any given day.
To find Insulin Analog, Lispro Mixed in stock near you, use medfinder — medfinder calls pharmacies in your area to check stock and texts you the results, so you don't have to spend hours on hold.
Insulin Analog, Lispro Mixed is not a controlled substance and does not require any special DEA registration or state-specific authority beyond a standard prescribing license. Any licensed prescriber with prescribing authority can order it for eligible adult patients.
Insulin prescriptions can also be issued via telehealth without additional restrictions. Telehealth platforms specializing in diabetes care — including Teladoc, Sesame, and endocrinology-focused services — can evaluate, prescribe, and manage insulin therapy for eligible patients remotely.
No. Insulin Analog, Lispro Mixed is not a controlled substance and is not scheduled by the DEA. It does not require special DEA registration to prescribe, and there are no refill restrictions based on controlled substance status. Any licensed prescriber — including physicians, nurse practitioners, and physician assistants — can prescribe it in all 50 states without additional authorization.
Prescriptions can be called in, faxed, or sent electronically. There are no mandatory in-person visit requirements or prescription quantity limits imposed by controlled substance law. State laws and insurance plan requirements may impose their own prescription limits, but these are not related to controlled substance scheduling.
The most common side effects include:
Serious side effects include:
Know what you need? Skip the search.
NovoLog Mix 70/30
Insulin aspart protamine/insulin aspart; 70% intermediate and 30% rapid-acting analog insulin by Novo Nordisk; closest pharmacodynamic substitute for Humalog Mix 75/25; similar BID dosing schedule
Humulin 70/30
Traditional human insulin mixture (70% NPH / 30% regular); slower onset requires 30-min pre-meal injection; less expensive; available OTC
Novolin 70/30
Traditional human insulin mixture (70% NPH / 30% regular) by Novo Nordisk; available OTC at Walmart; economical option; requires 30-min pre-meal timing
Basal-Bolus Therapy (Lantus/Tresiba + Humalog/Admelog)
Separate long-acting basal insulin plus rapid-acting mealtime insulin; more flexible and physiologically natural; allows independent dose titration; preferred for complex glycemic management
Prefer Insulin Analog, Lispro Mixed? We can find it.
Corticosteroids (prednisone, dexamethasone)
majorSignificantly reduce insulin effectiveness; may require major dose increases during steroid courses
Pioglitazone / Rosiglitazone (TZDs)
majorIncreased risk of fluid retention, weight gain, and heart failure when combined with insulin
Beta-blockers (metoprolol, atenolol, carvedilol)
moderateMask hypoglycemia warning signs (tachycardia, tremor); can still impair glycemic recovery
GLP-1 receptor agonists (Ozempic, Victoza, Trulicity)
moderateAdditive blood sugar-lowering effect; typically requires insulin dose reduction when starting GLP-1 therapy
Alcohol
moderateInhibits hepatic glucose release; significantly increases hypoglycemia risk; delayed effect possible hours after drinking
MAO inhibitors (phenelzine, selegiline)
moderateCan potentiate insulin's blood sugar-lowering effect; risk of severe hypoglycemia
ACE inhibitors / ARBs (lisinopril, losartan)
minorMay increase insulin sensitivity; monitor for hypoglycemia when initiating or adjusting dose
Thyroid replacement therapy (levothyroxine)
minorThyroid dose changes may alter insulin requirements; monitor blood glucose when thyroid dose changes
Insulin Analog, Lispro Mixed (Humalog Mix 75/25 and 50/50) is a well-established, clinically proven diabetes medication that provides both rapid mealtime coverage and extended background blood sugar control in a single twice-daily injection. For many patients with Type 1 or Type 2 diabetes, this premixed formulation offers a simpler regimen than separate basal and bolus injections.
The main challenges in 2026 are access and cost. Localized pharmacy stockouts continue despite the national supply having largely stabilized, and retail prices without discounts can be high. However, between the Lilly Insulin Value Program ($35/month), the Medicare IRA cap ($35/month), and GoodRx coupons, most patients have a realistic path to affordable access.
If you are struggling to find Insulin Analog, Lispro Mixed at your local pharmacy, medfinder can check multiple pharmacies near you and text you the results. You should never have to ration insulin or go without — help is available.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards